News


 Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology

Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology

March 24, 2025 12:03 PM AEDT| By Cision

Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 24, 2025 /PRNewswire/ -- As the demand for surgical precision and faster patient recovery continue...

 HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar

HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar

March 24, 2025 12:00 PM AEDT| By Cision

KUALA LUMPUR, Malaysia, March 24, 2025 /PRNewswire/ -- As the Hari Raya Aidilfitri celebration approaches, Hong Leong Bank and Hong Leong Islamic Bank ("HLB" or the "Bank") ha...

 ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

March 24, 2025 12:00 PM AEDT| By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901,...

 ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy

ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy

March 24, 2025 12:00 PM AEDT| By Cision

TAIPEI, March 24, 2025 /PRNewswire/ -- Continuous innovation in drone technology has become a key driving force behind the rapid development of the low-altitude economy. With the ongoing advancement o...

 FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

March 24, 2025 12:00 PM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- FuSure Reinsurance ("FuSure") is pleased to announce that, following four years of steady growth, it has successfully secured a long-term insur...

 Evolve: The Latest GPU Benchmark Suite

Evolve: The Latest GPU Benchmark Suite

March 24, 2025 11:30 AM AEDT| By Cision

Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ -- Traverse Research, one of the leading companies in graphics rese...

 CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

March 24, 2025 11:15 AM AEDT| By Cision

SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced...

 Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

March 24, 2025 11:15 AM AEDT| By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Exhibition & Convention Center on June 25-27. As...

 AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

March 24, 2025 11:00 AM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shing...

 Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

March 24, 2025 11:00 AM AEDT| By Cision

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures...

 Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

March 24, 2025 11:00 AM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announ...

 Strider Named to Fast Company's 2025 List of Most Innovative Companies

Strider Named to Fast Company's 2025 List of Most Innovative Companies

March 24, 2025 11:00 AM AEDT| By Cision

Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intellig...

 Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

March 24, 2025 10:56 AM AEDT| By Cision

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Eval...

 Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

March 24, 2025 10:30 AM AEDT| By Cision

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical deve...

 CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS

CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS

March 24, 2025 10:00 AM AEDT| By Cision

AUCKLAND, New Zealand, March 24, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in safety, security and risk-based engineering and consulting, today announced that its partner firm, Crossf...

 Confidence among small businesses in Singapore rises

Confidence among small businesses in Singapore rises

March 24, 2025 09:00 AM AEDT| By Cision

Business sentiment among small businesses in Singapore reached a five-year high in 2024, with a positive outlook expected to continue into 2025. Cybersecurity health improved. Sharp decline in...

 Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

March 24, 2025 08:00 AM AEDT| By Cision

CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones:...

 Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings

Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings

March 24, 2025 08:00 AM AEDT| By Cision

SEOUL, South Korea, March 24, 2025 /PRNewswire/ -- Hyundai Capital Services ("Hyundai Capital" or the "Company") announced today that its 12th financial subsidiary, Hyundai...

 Canopus Networks & UNSW Sydney Secure $433K Grant from Australian Government to Commercialize AI-Powered Cloud Security

Canopus Networks & UNSW Sydney Secure $433K Grant from Australian Government to Commercialize AI-Powered Cloud Security

March 24, 2025 06:00 AM AEDT| By Cision

Australian Government backs Canopus Networks and UNSW on AI Cyber Defense for SMEs SYDNEY, March 24, 2025 /PRNewswire/ -- Canopus Networks and UNSW Sydney have secured a $433K grant from the Australia...

 AV-Comparatives Launches Groundbreaking EDR Detection Validation Test -- Kaspersky Next EDR Expert Achieves Certification in Inaugural Assessment

AV-Comparatives Launches Groundbreaking EDR Detection Validation Test -- Kaspersky Next EDR Expert Achieves Certification in Inaugural Assessment

March 24, 2025 04:46 AM AEDT| By Cision

INNSBRUCK, Austria, March 24, 2025 /PRNewswire/ -- AV-Comparatives, a globally recognized independent authority in cybersecurity testing, is pleased to announce the certification of Kaspersky N...

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Recent Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.